Parameters |
PCR |
PLS |
HPLC |
Reported HPLC method |
NIF |
ATN |
NIF |
ATN |
NIF |
ATN |
NIF |
ATN |
Mean |
100.60 |
100.75 |
100.50 |
100.78 |
100.40 |
99.74 |
100.75 |
100.43 |
SD |
0.96 |
0.42 |
0.85 |
1.07 |
0.36 |
0.81 |
0.42 |
0.51 |
N |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
Variance |
0.92 |
0.18 |
0.72 |
1.14 |
0.12 |
0.65 |
0.18 |
0.26 |
t-test
(2.306)a |
0.33 |
0.52 |
0.59 |
0.65 |
1.39 |
1.58 |
- |
- |
F-test
(6.388)b |
5.11 |
4.58 |
4.04 |
4.38 |
1.32 |
2.54 |
- |
- |
|
aThe values in parentheses are the corresponding tabulated values at P<0.05. |
bHPLC method (C18 Agilent ODS column, (5μm, 250 mm×4.6mm, id. column), using methanol: acetonitrile: 0.025 M sodium dihydrogen phosphate 60:20:20 v/v/v and
adjusted to pH 3 with phosphoric acid, flow rate 1 mL/ min, 235 nm) |
Table 9: Statistical comparison of the results obtained by the proposed spectrophotometric and RP-HPLC methods and with the reported HPLC method [18] for the
analysis of nifedipine and atenolol in Tenolate® SR capsules. |